Clinical Trial Modernization, Outsourcing Concerns Are Focus Of FDA/Duke Effort
Executive Summary
In an FDA-Duke University Medical Center partnership to modernize the way clinical trials are conducted, close attention will be paid to the increase of outsourcing and off-shoring clinical trials
You may also be interested in...
Public/Private Initiative To Help FDA Modernize Guidance For Clinical Trials
Output from the Clinical Trials Transformation Initiative, whose executive board was named May 5, is expected to lead to new FDA clinical trial guidance
Public/Private Initiative To Help FDA Modernize Guidance For Clinical Trials
Output from the Clinical Trials Transformation Initiative, whose executive board was named May 5, is expected to lead to new FDA clinical trial guidance
Sponsors Often Compromise Ethics For Cost Efficiency With Trial Outsourcing
As drug sponsors opt to cut costs by outsourcing clinical trials to emerging nations such as India, incomplete patient consent forms are one of several rising ethical concerns linked to such demand